Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Enteral Nutrition (EN) A meta-analysis attests to the feasibility of early postoperative EN in high-risk surgical patients and that these patients have reduced septic morbidity rates compared with those administered PN.”{Moore et al., 1992, #79138} Patient Case • 65-year-old male admitted for respiratory failure 13 days ago. • PMH: HTN, CAD, COPD, CRF with dialysis MWF • Hypotensive event after admission, now on low dose dopamine • Ventilated on sedation protocol (fentanyl/lorazepam) • TF started 4 days ago. Held for residuals of 150 ml. • Metoclopramide initiated 5 mg IV Q6h Last BM prior to arrival, and Bowel Sounds Minimal • • Abnormal Labs K-5.2, Cl 116 , CO2-21, BUN-63, Cr-7.9, Alb-2 3, Phos-6.6 MAP 68, no boluses • Anthropometrics include: Ht 73 inches, Wt 79 kg, BMI 23 kg/m2 Pharmacist is asked to evaluate patient for TPN Indications for Enteral Nutrition (EN) Estimated time to oral intake. (NOT waiting for this endpoint, but upfront evaluating when to start EN) • Well nourished 10 – 14 days • ICU > 5 days • Poorly nourished non ICU ? Pts with adequately functional GI tract whose oral calorie/nutrient intake is insufficient to meet needs • Poor appetite, Hypermetabolism, Neurological disease/injury, GI disease, Oncologic disease, Psychiatric disorders, and Organ failure Contraindications to Enteral Nutrition • • • • • • • Inability to access the GI tract Insufficient absorptive capacity Obstruction of GI tract Prolonged ileus Severe GI hemorrhage Severe diarrhea Intractable vomiting • • • • • High output fistula (proximal versus distal) Abdominal trauma Bowel ischemia Severe Pancreatitis Terminal illness Feeding the Hypotensive Patient • Hypotensive patients are probably NOT good candidates for EN, because of issues with oxygen competition resulting in ischemic gut which can result in a catastrophic complication. • MAP < 60 mm/hg • Bolus IV fluid requirements b/c of hypotension • Increasing doses of pressor agents • Addition of multiple pressors Enteral Feeding Myths • No Bowel Sounds • Lack of bowel sounds does not preclude or contraindicate safe enteral nutrition (EN) • Other parts of the gastrointestinal tract may be working. This can happen where we have a gastric ileus causing the stomach not work appropriately. • Patients without bowel sounds can be fed safely with EN • Enteral Feeding causes diarrhea 1 Most often it is NOT the enteral feeding, but exacerbating factors and medications that cause diarrhea. Hyperosmolar liquid formulations (elixirs), sorbitol content, antibiotics (killing normal flora), bacterial overgrowth, impaction, malabsorption, lack of fiber Aspiration risk • Two feedings can be aspirated. The question is the EN the cause of aspiration? NO • In this situation we need to be vigilant, but not panicky about aspiration Oropharangeal secretions aspiration versus EN contents • • EN may actually decrease risk of aspiration • • Enteral Feeding Advantages • Physiologic feeding – as opposed to intravenous nutrition • Metabolic – feeding into the intestinal tract allows the body to respond more normally causing significantly fewer metabolic complications • Immunologic – Enteral feeding allows the body to process foods in a more normal manner stimulating immune function. • Safety – Enteral tubes are much safer than a central line. • Cheaper Attenuation of Hepatic Protein Reprioritization{Peterson et al., 1988, #75631} • Peterson, et al, 1988. They discovered this by measuring positive acute phase reactants to alpha antichymotrypsin which showed enteral feeding decreased the liver’s production of this protein which is used to describe metabolic stress response ★ Results: early enteral feeding showed decrease STRESS response Intestinal Immunology Mucosal (barrier functions) • Gastric acidity – Kills bacteria • Normal bowel flora – Blocks absorption of toxins and unwanted bacteria • Intraluminal proteases – Break down toxins • Peristalsis – Moves toxins through the GI tract • Globular cell mucus • Normal enterocyte membrane composition GALT (gut associated lymphoid tissue) • Peyers patches • Antigen presenting cells and lymphocytes (lamina propria) • Intraepithelial lymphocytes • Mesenteric lymph nodes • 1010 Ig producing cells/Meter small bowel (70%) • 10gms sIgA daily Immunologic Gut-associated lymphoid Tissue (GALT) • 25% of intestinal mucosa is lymphoid • 70 – 80% of ALL immunologic secreting cells in the body are associated with the GI tract • Largest immune organ in the body • Supplies immune function for the OTHER mucosal organs, (e.g.) Genitourinary tract, pulmonary, and the gastrointestinal tract. Factors affecting the GALT • What could affect the secretion of IgA & sIgA? • Decreased fuel if not feeding into the gut. • Decreased fuel GI stimulation (Hypoplasia seen as decreased villi height) Bacterial Translocation Bacterial translocation is the movement of bacteria and endotoxins through the lining of the intestinal tract in a way that it overloads the lymph system, AND the reticular endothelial system leaving us with what is referred to as gut derived sepsis. • Bacteria or endotoxins 2 • • • • Normal occurrence Normally handled by the reticuloendothelial system Increased when barrier defenses damaged Increased when GALT function is affected, because we get lower amounts of sIgA. • Healthy GI Tract with a good mucosal protective layer. Here you have adequate protective flora protecting the endothelial cells from bacteria that may adhere to them and be translocated. NOT adequately feeding the gastrointestinal tract. There is breakdown of the mucoid layer, and loss of the friendly flora. This results in bacterial translocation. • 8 healthy parenteral nutrition (PN) for 2 weeks, and THEN a second biopsy showed results{Buchman et al., 1995, #52694} • The results where that the volunteers lost 50% of their villi height in that short amount of time. ★ This is due from not stimulating the gastrointestinal tract with enteral nutrients. • Enteral Feeding Disadvantages • Disadvantages of enteral feeding include the outcome of having a patient who has a decubitus ulcer or other types of wounds that could be soiled by POOP! Colostomy have been placed to allow for healing of these ulcers. • Another disadvantage gut ischemia (caused by hypotension) Some of the indirect complications include aspiration that results from poor motility, and subsequent vomiting • Indirect (complications) • Aspiration → ileus or vomiting • Infection, injury, or leakage from tubes or tube sites • Diarrhea → toxins, sterile gut, slick gut, over treatment of constipation, or osmotic agents Feeding Locations Insertion site • Nasal • Oral • Abdominal Feeding location • Gastric • Duodenal • Jejunal Types of tubes • Nasogastric tube, Nasojejunal tube, percutaneous endoscopic gastrostomy tube (PEG Tube), Laparoscopic placed jejunostomy tube, Percutaneous endoscopic gastrojejunostomy, gastroduodenal tube. Gastric Placement Advantages • Decreased stress bleeding • Less diarrhea • Ease of access • Lower cost Transpyloric Advantages • Bypass gastric ileus or obstruction • Decreased risk of aspiration • Less stimulation of the biliary tree • Don’t have to check residuals Enteral Administration When do we start the process of enteral administration? EARLY • Sooner? (or later?), 6 hours post admit?, 24 hours post admit?, 72 hours post admit?, Next year?, Nutritional Risk?, Hemodynamics? • Good data shows burn patients should start 6 hours after INJURY 3 Timing • Early is better Early Enteral Feeding • ASPEN (American) • Enteral feeding should be started within the first 48 hours after admission • Feedings should be advanced to goal over the next 48-72 hours • ESPEN (European) • All patients not EXPECTED to have full oral intake within 3 days should receive enteral nutrition • Expert committee recommends feeding the hemodynamically stable ICU patient within 24 hours Caloric Deficit “a Debt That Must Be Paid” • Clinical nutrition week in 2010 – Caloric Deficit > 10,000 kcal = 86% death. Early Enteral Feeding • Within 48 hours – here we may not get to goal, but 25% of goal rate will stimulate immune function within the gut. • Trophic rates • Helps maintain immune function • Decreases acute phase response • May improve tolerance to enteral feeding • Non-ICU patients – May not have to be as aggressive but again sooner is better than later How do we implement this enteral feeding? • Continuous gravity feedings • Intermittent gravity feedings • Bolus with a syringe • Pump controlled either all day or night feedings OR Cycled Goal Rates How fast we run enteral feeding? • Not everyone gets100ml/hour • Here we consider types of tube feeding, nutritional needs, and caloric assessment • Each patient needs to be individualized both with their feeding, rate, and amount. • Check goal assessment and compare to kcal/ml • Always start at FULL strength. There is NO advantage to half strength • Start at 25% of goal (roughly 25 to 30 mL per hour) • Advance 10-20 mL Q4-6 hrs as tolerated to goal rate (~48 hrs) • Not everyone will tolerate rapid advances • Be careful when turning off or on feedings • When turning feedings off we need to make sure that they are then turned back ON soon. Monitoring Tolerance of Enteral Feedings • Vomiting – Which could cause us to stop EF • Lactose intolerance – most of the enteral feedings are lactose FREE • Gastric ileus – This concerns us when our gastric residual volumes (GRV) are > 800 mL – 1000 mL • Having a gastric ileus could lead to Aspiration • Abdominal distention • Diarrhea – treat and understand causes in the process of enteral feeding. • Constipation Aspiration 4 • • • • Aspiration – Inhalation of material into the airway below the level of the vocal cords “stuff in your lungs” Leading cause of pneumonia in the ICU Most serious side effect of enteral feeding Risk may decreased by effective enteral feeding Major Risk factors for Aspiration • Documented previous episode of aspiration • Decreased level of consciousness which leads to the inability to swallow • Endotracheal intubation • Vomiting • Persistently high gastric residuals • Need for prolonged supine position (lying flat) ★ Have the bed with at least 30° incline Methods of Aspiration Monitoring • Glucose oxidation monitoring – shown not to be effective in monitoring for aspiration • Blue dye coloring • Gastric residual volumes • Most effective are: Video fluoroscopy, endoscopic laryngoscopy, Scintigraphy BUT all are difficult within a hospital setting Blue Dye Coloring - 49 • FD&C Blue #1 & Methylene blue • Issues • Amounts not standard, Risk of Contamination (serious and immunocompromised patients), and Breaking sterile product Warning against using BLUE coloring by FDA • 20 reported cases due to this blue intestine, 12 deaths (hypotension and metabolic acidosis), Septic patients with increased gut permeability • FD&C #1 is a poison to Mitochondrial • “Other blue dyes, such as methylene blue and FD&C Blue No. 2, may have similar if not greater toxicity potential than Blue 1 and would not be appropriate replacements.” • “This practice should be abandoned” Consensus statement 2003 (FDA public health advisory) Gastric Residual Volumes (GRV) • Poorly standardized • Correlate poorly with gastric emptying • Correlate poorly with volume of gastric contents • Correlate poorly with volume of enteral feeding • Correlate poorly with regurgitation • DOES impede provision of nutrition Gastric Residual Recommendations ★ If the gastric residual volume GRV is > 500 ml withhold feeding and reassess tolerance. • GRV < 500 ml should be returned to the patient with continued monitoring. • GRV 200 ml –500 ml do not confirm tolerance and should initiate activities to reduce risk. • GRV < 200 ml seem to be well tolerated but evaluation should continue. How to Improve Tolerance • Prokinetic agents 5 • • • • Increase the Head of Bed Log roll to help with gastric emptying Bowel Programs especially with patients on high dose Opiates Increase concentration by using a 2 calorie per milliliter formulation rather than a 1 cal per milliliter which decreases the amount of volume presented to the stomach. Prokinetic agents • Metaclopramide, Cisapride, Erythromycin (~200mg q12hrs), Choline/dexpanethol. Domperidone, Tegaserod, Methylnaltrexone, Alvimopan, Sildenafil • Metoclopramide and erythromycin are the two most common in the United States. • Cisapride is available in other countries, and is available in the United States in a restricted manner • Methylnaltrexone and Alvimopan are newer opioid antagonist agents. Mechanical Complications • Tube malposition – Perforation & Pneumonia (Tubes inadvertently placed in the lungs causing pneumonia) • Tube clogging – Feeding can clog the tubes (FLUSH!) • Enzymes can break down this clog that has developed • Mechanical means with different types of brushes that breaks up the clot • Crushed medication causes many issues with clogging tubes • Mechanical means is the only way to clear medication blockage Monitoring Effectiveness of Enteral feeding • UUN - Urine urea nitrogen (24-hour nitrogen balance) • Metabolic carts • Prealbumin & C reactive proteins (CPR) • Electrolytes • Hydration status – Free H2O additions is recommended for dehydrated patients Alternatives to Continuous Feeding Cycling • Some patients may be eating, but just not enough yet. In this case we can infuse their tube feedings at night allowing them to improve their oral intake. • Total needs OR 50-60% of needs, may give for 12 hours during the night Bolus feeding – infusing 200mL to 500mL at one time during meal times • More physiologic, A better process for Rehab patients Allows for mobility so the patient can move around ISSUES with Enteral Feeding and Medication Binding • Ciprofloxacin & Phenytoin (dilute ?) Crushing medications • Everyone should have a list of medications that CANNOT be crushed available • Certainly not any sustained release • Liquids where possible – Be aware of Alcohol and Sorbitol concentrations. Delivery site – Don’t deliver gastric absorbed drug it into the small intestine. Enteral Formulas 6 Standard Polymeric Fibersource HN, Jevity, Nutren, Ensure, Boost • 1 - 1.2 kcal/cc • Whole proteins 35 - 45 gm/1000 kcals • Most with Fiber • Moderate nitrogen • Some can be taken orally • May not be beneficial in highly catabolic patient patient • Not recommended to be used with tubes High Nitrogen Isosource VHN, Promote, Replete, Traumacal • 1.0 kcals/cc • Whole proteins 60 gm/1000 kcals • Fiber • These of the formulas used in trauma units, burn units, or any patient that are severely catabolic or protein loosing for various reasons. Moderately Low Volume Isosource 1.5, Nutren 1.5 • 1.5 kcals/cc • Fiber • Moderate protein • Used in patients that may require fluid restriction, or not tolerating excessive amounts of volume because of a 1 calorie per milliliter formula. Low Volume Polymeric Novasource 2.0, Deliver 2.0, Twocal, Nutren 2.0 • 2.0 kcals/cc • No fiber • Moderate protein • Used in patients that require fluid restriction (e.g CHF) • Used in patients that have a high volume intolerance. • These formulations can be administered at a lower rate, and give the same amount of protein and calories. Elemental Formulas Vivonex Plus, Vivonex HN, Vivonex TEN, Vital HN, Tolerex • 1 kcal/cc • Free Amino acids are the protein source • No fiber • Moderate protein • These formulas or for patients who show intolerance to whole proteins. • They may decrease diarrhea in patients that are whole protein intolerant. Semi-elemental Formulas Peptamen, Subdue • 1 kcal/cc • Shorter chain peptides which are easily absorbed without an energy requirement to break down for absorption • They are not truly free amino acids • No fiber • Moderate protein • Increased MCT as fat component which are easily absorbed • These formulas are used in patients where you have questionable ability for absorption (fistula) Enteral Formulas 7 Renal Formulas NovaSource Renal, Nepro, NutriRenal • 2 kcals/cc • Whole proteins • No fiber • Average protein • Lower fluid, and lower electrolytes (K, Mag, Phos) which are needed in renal failure patients • These formulas or for renal failure patients WITH dialysis. • These patients have a fluid restriction, but need adequate proteins (aggressive proteins) Hepatic Formulas NutraHep, HepaticAid • 1.5 kcal/cc • Increased branched chain amino acids – 37gm/1000 kcals • No fiber • Lower protein • Low sodium • Minimal amounts of ammonia are released with these formulas. • These formulas are mainly used with patients who are comatose with encephalopathy. Very Low Protein Formulas Suplena, Renalcal • 2 kcals/cc • Whole proteins • No fiber • These formulas or for patients who TRULY need protein restriction. This primarily includes patients who are with renal failure, but are not yet undergoing dialysis Diabetic Formulas Diabetasource AC, Glucerna, Glytrol • 1 - 1.2 kcal/cc • Whole proteins • Fiber • Moderate protein • Decreased carbohydrate and increased fat • Exposing a patient to lower carbohydrates will give better glucose control. Pulmonary Formulas Novasource Pulmonary, Pulmocare, Respalor, Nutrivent • 1.5 kcal/cc • Whole proteins • No fiber • Moderate protein • Increased fat and decreased carbohydrate • Same as diabetic formulas • Pulmonary patients are retainers of carbon dioxide. Immune Enhancing Formulas Crucial, Impact, Pivot • Glutamine • Arginine • Antioxidants • Increased levels of omega-3 fatty acids • Reduced Omega 6 fatty acids • Nucleotides • These formulations attempt to minimize the stress response & sepsis Oxepa • 1.5 kcal/cc • Whole proteins 42 gm/1000 kcals • No fiber • Average protein • 45-55% total kcals lipid • Oxepa specific indication for adult respiratory distress syndrome (ARDS) lowers inflammation Food Based Formula Compleat • 1.07 kcal/ml • Whole proteins 40gm/1000 kcals • Fiber • 30% fat • Moderate protein • This is a food-based formula Modular Additions Modular additions to our tube feeding can be added. This includes extra protein, extra glucose, extra fat, MCT oil, all of which help us modify the diet in ratios that are not of standard formulas. • Additions to TFs – ProMod, Casec, Moducal, Polycose, MCT oil, Microlipid 8 Patient Case Issues • Waited 10 days to start EN. We waited TOO long to start enteral nutrition. • Hypotensive event now stable • Residual cutoff too low (150ml) → Cutoff should have been at a MINIMUM of 200 mL • Constipation with continuous fentanyl → needs bowel program • Dialysis with high K and phos → needs renal formula • Caloric deficit too high → needs nutrition NOW probably need to start PN until enteral tolerated Take Home Message • Enteral nutrition better then Parenteral nutrition • Early enteral better • Start at 25% of goal • Advance over 48-72 hours • HOB > 30 degrees • GRV every 4 hours (200) • Bowel program started early on especially with patients on narcotics • Prokinetics • NO BLUE DYE 9